Matrix metalloproteinase 3 and 9 as genetic biomarkers for the occurrence of cardiovascular complications in coronary artery disease: a prospective cohort study-Reference-Cited by-同舟云学术

Matrix metalloproteinase 3 and 9 as genetic biomarkers for the occurrence of cardiovascular complications in coronary artery disease: a prospective cohort study

Published:2022-08-12 Issue:10 Volume:49 Page:9171-9179
ISSN:0301-4851
Container-title:Molecular Biology Reports
language:en
Short-container-title:Mol Biol Rep

Author:

Guizani Imen,Zidi Wiem,Zayani Yosra,Nesrine Fourti,Douik Hayet,Sanhaji Haifa,Mourali Mohamed Sami,Feki Moncef,Allal-Elasmi Monia

Publisher

Springer Science and Business Media LLC

Subject

Genetics,Molecular Biology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s11033-022-07742-1.pdf

Reference31 articles.

1. Henney AM, Wakeley PR, Davies MJ, Foster K, Hembry R, Murphy G, Humphries S (1991) Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization. Proc Natl Acad Sci U S A 88(18):8154–8158. https://doi.org/10.1073/pnas.88.18.8154

2. Van den Steen PE, Dubois B, Nelissen I, Rudd PM, Dwek RA, Opdenakker G (2002) Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9). Crit Rev Biochem Mol Biol 6:375–536. https://doi.org/10.1080/10409230290771546

3. Jefferis BJ, Whincup P, Welsh P, Wannamethee G, Rumley A, Lennon L, Thomson A, Lawlor D, Carson C, Ebrahim S, Lowe G (2010) Prospective study of matrix metalloproteinase-9 and risk of myocardial infarction and stroke in older men and women. Atherosclerosis 208(2):557–563. https://doi.org/10.1016/j.atherosclerosis.2009.08.018

4. Galis ZS, Johnson C, Godin D, Magid R, Shipley JM, Seniorv RM, Ivan E (2002) Targeted disruption of the matrix metalloproteinase-9 gene impairs smooth muscle cell migration and geometrical arterial remodeling. Circ Res 91:852–859. https://doi.org/10.1161/01.res.0000041036.86977.14

5. Wågsäter D, Zhu C, Björkegren J, Skogsberg J, Eriksson P (2011) MMP-2 and MMP-9 are prominent matrix metalloproteinases during atherosclerosis development in the Ldlr(-/-)Apob(100/100) mouse. Int J Mol Med 28:247–253. https://doi.org/10.3892/ijmm.2011.693

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Matrix metalloproteinase-3 joins a growing list of proteases that regulate vascular calcification;Cardiovascular Research;2024-04

2. A Set of Possible Markers for Monitoring Heart Failure and Cognitive Impairment Associated: A Review of Literature from the Past 5 Years;Biomolecules;2024-02-03

3. Allelic variant 6A (rs35068180) of the MMP-3 promoter region as a predictor of cardiotoxicity after the end of adjuvant chemotherapy with doxorubicin in patients with breast cancer;Russian Journal of Cardiology;2023-10-16

4. Clinical application of MMP-3 in evaluating bone erosion in gouty arthritis;2023-07-13

5. IGF2BP3 promotes adult myocardial regeneration by stabilizing MMP3 mRNA through interaction with m6A modification;Cell Death Discovery;2023-05-15